Abstract
Most patients with ABC have HER2-negative (HER2-) disease. This study described management of HER2- ABC in the US and EU3 (France, Italy, Spain) by line of treatment and assess the influence of these factors on physician and patient treatment satisfaction.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
